news Eisai, Biogen's lecanemab slows Alzheimer's decline in phase 3 – FiercePharma alex mun October 13, 2022 1 min read Eisai, Biogen’s lecanemab slows Alzheimer’s decline in phase 3 FiercePharmasource Chat read-only to anonymous users. Chat with Anyone and Anywhere. Only registered users are allowed to send messages. Loading the chat ... 25572 Register Login Continue Reading Previous: Queenstown staff shortages continue with at least 600 vacancies in town – RNZNext: NZ footballer suspended over alleged insider betting – 1News Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ